St. Luke's Medical Center's DNA-based molecular diagnostic tests for Hepatitis B virus:
Since 2001 St. Luke’s Medical Center (SLMC) has been conducting various DNA-based molecular diagnostic tests for hepatitis B virus (HBV) through the Research and Biotechnology Division (RBD). These services which include detection, viral load determination, and genotyping of HBV are based on the Polymerase Chain Reaction (PCR) technique, a rapid and highly accurate method. The procedures used are an offshoot of researches on liver diseases at the RBD of St. Luke’s Medical Center.
There are 3 different tests available at St. Luke’s:
• Detection - The hepatitis DNA present in the blood of patients
is enzymatically amplified by PCR, visualized and identified by molecular
A similar set of tests for hepatitis C virus infections, using RNA detection methods is also offered.
For the past 5 years, liver patients at St. Luke’s and other medical institutions in the country have availed of these tests. Patrons of the HBV tests at SLMC include hospitals from Cebu, Iloilo, Leyte, Davao, Central Luzon, Pampanga, Laguna, and Cavite. Hospitals such as Philippine General Hospital, Makati Medical Center, Asian Hospital, Manila Doctors Hospital, Cardinal Santos Medical Center, Medical City, Capitol Medical Center, Our Lady of Lourdes Hospital, among others, have availed of these same services from St. Luke's.
At present, RBD is upgrading these services to include real-time PCR and microarray technology in its bid to remain at the forefront of liver disease healthcare in the region.
For more information, please contact:
Filipinas F. Natividad, PhD